Oncology Pipeline
Four active molecules spanning discovery through commercialization, organized by modality and lifecycle stage.
Pipeline Swim Lane
Molecules by modality category across development stages
Lifecycle Map
All molecules positioned on the 12-stage pharma lifecycle
Active Molecules
Summary cards for each molecule in the Mays portfolio
Phase
1/2
Lifecycle Stage
Stage 3: Phase 1 Clinical
Phase
1/2
Lifecycle Stage
Stage 4: Phase 2 Clinical
Phase
1/2 (completed)
Lifecycle Stage
Stage 4: Phase 2 Clinical
Stage
Preclinical
Lifecycle Stage
Stage 1: Lead Optimization
Stage
Lead Optimization
Lifecycle Stage
Stage 1: Lead Optimization
Stage
Hit-to-Lead
Lifecycle Stage
Stage 0: Target Discovery
Stage
IND-Enabling
Lifecycle Stage
Stage 2: Preclinical Development
Stage
IND-Enabling
Lifecycle Stage
Stage 2: Preclinical Development
Stage
Preclinical
Lifecycle Stage
Stage 1: Lead Optimization
Stage
Preclinical
Lifecycle Stage
Stage 1: Lead Optimization
Stage
Discovery
Lifecycle Stage
Stage 0: Target Discovery
Phase
2
Lifecycle Stage
Stage 3: Phase 1 Clinical
Phase
1
Lifecycle Stage
Stage 2: Preclinical Development
Phase
2
Lifecycle Stage
Stage 3: Phase 1 Clinical
Phase
1
Lifecycle Stage
Stage 3: Phase 1 Clinical
Phase
2
Lifecycle Stage
Stage 3: Phase 1 Clinical
Phase
1b
Lifecycle Stage
Stage 3: Phase 1 Clinical
Phase
2
Lifecycle Stage
Stage 3: Phase 1 Clinical
Phase
2
Lifecycle Stage
Stage 3: Phase 1 Clinical
Phase
2
Lifecycle Stage
Stage 3: Phase 1 Clinical
Phase
Early Phase 1
Lifecycle Stage
Stage 3: Phase 1 Clinical
Status
Commercial
Lifecycle Stage
Stage 8: Peak Commercialization
FDA
2022
Lifecycle Stage
Stage 11: Loss of Exclusivity
FDA
2021
Lifecycle Stage
Stage 11: Loss of Exclusivity
FDA
2019
Lifecycle Stage
Stage 11: Loss of Exclusivity
FDA
2023
Lifecycle Stage
Stage 11: Loss of Exclusivity
FDA
2023
Lifecycle Stage
Stage 11: Loss of Exclusivity